The following recommendations were updated by NTAG at their meeting on the 23rd February 2021 and are now available on the website:

  • Flash Glucose Monitoring – updated to include Learning Disability on insulin, and use in pregnancy on insulin with Type 2 diabetes as additional criteria. Plus information on switch to Freestyle Libre 2 and extra guidance on use in Type 1 diabetes patient with high HbA1c.
  • Teriparatide for atypical bisphosphonate induced fractures – reviewed and no changes made.
  • Doxylamine/Pyridoxine (Xonvea®) for nausea & vomiting in pregnancy – reviewed and no changes made.

The recommendations were archived by NTAG at their meeting on the 23rd February 2021 as now superseded by NICE TA or NHSE guidance:

  • Erenumab and galcanezumab for prophylaxis of migraine
  • Brolucizumab for wAMD